Immutep Announces First-in-Human Phase I Study of IMP761 Progresses to Dose Escalation Portion of Trial
Posted: 21 October 2024 Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease, today announces that the first part (Part A, single dose) of the…
MTPConnect Cements US Medtech Links Through MoU with Influential Medical Alley
Posted: 21 October 2024 MTPConnect, Australia’s life science innovation accelerator, and Medical Alley, headquartered in Minnesota have committed to ongoing collaboration to support the growth of medtech companies with the signing today of a Memorandum of Understanding. The…
$22 million investment in cancer clinical trials to save lives throughout Australia
Posted: 21 October 2024 The Minister for Health and Aged Care, the Hon Mark Butler MP, today announced the successful applicants for the 2024-2027 Support for Cancer Clinical Trials (Clinical Trials) program, with a total of $22.19 million…
Recruitment Restarts in Accent Pancreatic Cancer Trial
Posted: 21 October 2024 Amplia has announced that recruitment of the final cohort of patients in the ACCENT clinical trial has begun with the first patient having started on trial this week. A total of 50 patients are…
South African and Australian health product regulators to share regulatory information and expertise
Posted: 14 October 2024 The South African Health Products Regulatory Authority (SAHPRA) and the Australian Therapeutic Goods Administration (TGA) have signed a Memorandum of Understanding (MoU), which will strengthen collaboration between the two health product regulators. The MoU…
2024 Prime Minister’s Prize for Innovation
Posted: 9 October 2024 Cytopia’s Professor Andrew F Wilks and Dr Chris Burns received the 2024 Prime Minister’s Prize for Innovation. The prize recognises their outstanding contribution to drug discovery and development in Australia. Prof Wilks and Dr Burns…
Immutep Completes Patient Enrolment in Randomised Phase II of AIPAC-003 Trial in Metastatic Breast Cancer
Posted: 8 October 2024 Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease, today announces patient enrolment has been completed in the randomised Phase…
New drug could be answer to an overlooked yet devastating type of dementia
Posted: 8 October 2024 Monash University researchers are assessing a new drug that could be a game changer for the dementia that has struck US actor Bruce Willis, and countless others as young as 35: behavioural variant frontotemporal…
World first: Australian scientists uncover “plant-like” behaviour in important human cell regulator, opening up a new drug target for cancer, other diseases
Posted: 8 October 2024 A team of scientists from Monash University has solved the structure of a protein known as ‘LYCHOS’, which can detect and regulate cell growth by sensing cholesterol levels in the body. Human cells need…
Cartherics raises over $15 Million in oversubscribed private financing round to advance cell therapy programs
Posted: 2 October 2024 Cartherics Pty Ltd (“Cartherics” or “Company”), a biotechnology company developing immune cell therapies for the treatment of cancer and other diseases, is pleased to announce that it has successfully raised well over its target AU$15M…
First human vagus nerve recordings pinpoint cardiovascular signals
Posted: 2 October 2024 The team that first recorded vagus nerve signals in humans has isolated the electrical activity of individual neurones responsible for cardiovascular regulation. Published in The Journal of Physiology, the Monash University-led discovery paves the way…
Professor Emma Johnston AO appointed new Vice-Chancellor
Posted: 2 October 2024 University of Melbourne Chancellor, Jane Hansen AO, today announced the appointment of Professor Emma Johnston AO as the 21st Vice-Chancellor of the University of Melbourne. Professor Johnston is the first woman to be appointed…
